Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | WRN | Q14191 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15209267 | 0.87 | CHRM2 (0.38) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL509161 | 0.86 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL17418540 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL28948510 | 0.82 | CYP2D6 (0.33) | CYP2C19 | |
| SCHEMBL12804642 | 0.81 | NAAA (0.45) | — | |
| SCHEMBL17418777 | 0.81 | — | — | |
| SCHEMBL2518307 | 0.81 | — | — | |
| SCHEMBL1900634 | 0.81 | — | — | |
| SCHEMBL358903 | 0.78 | — | — | |
| SCHEMBL3126569 | 0.78 | TSHR (0.33) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841441-B2 | Method for producing regenerated biopolymers and regenerated products obtained by said method | BASF SE (DE) | 2014-09-23 | — | — | US | claimed |
| EP-1966284-B1 | SOLVENT SYSTEM BASED ON MOLTEN IONIC LIQUIDS, ITS PRODUCTION AND USE FOR PRODUCING REGENERATED CARBOHYDRATES | BASF SE (DE) | 2013-04-17 | — | — | EP | claimed |
| US-8163215-B2 | Contains 1-ethyl-3-methylimidazolium acetate; precipitation; spun fibers | BASF AKTIENGESELLSCHAFT (DE) | 2012-04-24 | — | — | US | claimed |
| US-20120095207-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2012-04-19 | — | — | US | claimed |
| US-8153782-B2 | Cellulose esterification; ion exchanging; acylation; slurrying | EASTMAN CHEMICAL COMPANY (US) | 2012-04-10 | — | — | US | claimed |
| US-8148518-B2 | Cellulose esterification; ion exchanging; acylation; slurrying | EASTMAN CHEMICAL COMPANY (US) | 2012-04-03 | — | — | US | claimed |
| US-7919631-B2 | Production of ionic liquids | EASTMAN CHEMICAL COMPANY (US) | 2011-04-05 | — | — | US | claimed |
| US-20100256352-A1 | METHOD FOR PRODUCING REGENERATED BIOPOLYMERS AND REGENERATED PRODUCTS OBTAINED BY SAID METHOD | BASF SE (DE) | 2010-10-07 | — | — | US | claimed |
| EP-2121766-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-25 | — | — | EP | claimed |
| EP-2118070-A1 | PRODUCTION OF IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-18 | — | — | EP | claimed |
| EP-2118143-A1 | REFORMATION OF IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-18 | — | — | EP | claimed |
| US-20080269477-A1 | Solvent System Based on Molten Ionic Liquids, Its Production and Use for Producing Regenerated Carbohydrates | BASF SE (DE) | 2008-10-30 | — | — | US | claimed |
| WO-2008100569-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| WO-2008100577-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| WO-2008100566-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
| US-20080194807-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
| US-12589350-B2 | Composition for carbon dioxide absorption | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | GLUL, ICMT, ALAD | CHRM2 2069/4885CHRM4 2250/4885CHRM1 2332/4885 |
| US-12589350-B2 | Composition for carbon dioxide absorption | CA1, CA13, CA2 | CHRM2 31/4885CHRM4 243/4885CHRM1 9/4885 |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | CEL, ACMSD, ACOT7 | CHRM2 2688/4885CHRM4 1109/4885CHRM1 2080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.